Chemoprevention options for BRCA1 and BRCA2 mutation carriers

Journal of Clinical Oncology

Volumn 18, Issue 21 SUPPL., 2000, Pages

  Eeles, Rosalind A ^a   Powles, Trevor J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; GENE MUTATION; HUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW;

ANTICARCINOGENIC AGENTS; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; TAMOXIFEN; TRANSCRIPTION FACTORS;

EID: 0034331054     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. The contribution of inherited predisposition to cancer incidence
2. Genetic analysis of breast cancer in the Cancer and Steroid Hormone study
3. Breast and ovarian cancer incidence in BRCA1 carriers: Breast cancer linkage consortium
4. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA 1
5. Identification of a breast cancer gene, BRCA2
6. Estimates of the gene frequency of BRCA 1 and its contribution to breast and ovarian cancer incidence
7. Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA2 genes in breast cancer families
8. Risks of cancer in BRCA1-mutation carriers
9. Mutation analysis of the BRCA2 gene 49 site-specific breast cancer families
10. Breast cancer linkage consortium: Carriers risks in BRCA2 mutation carriers
11. The risk of cancer associated with specific mutations of BRCA 1 and BRCA2 among Ashkenazi Jews
12. Population-based study of risk of breast cancer in carriers of BRCA2 mutation
13. Germline mutations of the BRCA1 gene in breast/ovarian cancer families: Evidence for a genotype/phenotype correlation
14. BRCA 1/2 carriers and endocrine risk modifiers
15. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene
16. BRCA 1 sequence analysis in women at high risk for susceptibility mutations
17. BRCA 1 mutations in a population-based sample of young women with breast cancer
18. Prevalence of BRCA 1 and BRCA2 gene mutations in patients with early onset breast cancer
19. Familial predisposition to breast cancer in a British population: Implications for prevention
20. The epidemiology and etiology of breast cancer
21. Anti-oestrogen action in experimental breast cancer
22. Comparative anti-oestrogen action in experimental breast cancer
23. A review of the epidemiology of human breast cancer
24. Study of epidemiology of cancer of the breast: Influence of hysterectomy
25. Oral contraceptives and breast cancer: Latest findings in a large cohort study
26. Collaborative Group on Hormonal Factors in Cancer: Breast cancer and hormone replacement therapy: Collaborative re-analysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
27. Tamoxifen for early breast cancer: An overview of the randomised trials
28. Early Breast Cancer Trialist Collaborative Group: Ovarian ablation in early breast cancer: Overview of the randomised trials
29. Malignant breast tumours among atomic bomb survivors, Hiroshima and Nagasaki, 1950- 74
30. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA 1 mutation carders
31. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
32. Projecting individualised probabilities of developing breast cancer for white females who are being examined annually
33. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
34. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women - Italian Tamoxifen Prevention Study
35. Tamoxifen for the prevention of breast cancer
36. Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA2 genes in breast cancer families
37. A detailed analysis of the morphological features associated with breast cancer in patients harbouring mutations in BRCA 1 and BRCA2 predisposition genes
38. Raloxifene reduces incident primary breast cancers: Integrated data from multicentre, double-blinded, placebo-controlled, randomised trials in post menopausal women
39. Oral contraceptives and the risk of hereditary ovarian cancer
40. The effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomised control trial - Nutritional Prevention of Cancer Study Group
41. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17 Year follow-up of the prospective Basel study